These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3152454)

  • 1. Combined prostacyclin and thromboxane synthetase inhibitor UK 38485 in flap survival.
    Zachary LS; Heggers JP; Robson MC; Murphy RC
    Ann Plast Surg; 1986 Aug; 17(2):112-5. PubMed ID: 3152454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin and prostanoid modifiers aid ischemic skin flap survival.
    Knight KR; Kawabata H; Coe SA; Angus JA; O'Brien BM; Sakai K
    J Surg Res; 1991 Feb; 50(2):119-23. PubMed ID: 1990215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intraarterial prostacyclin on survival of skin flaps in the pig: biphasic response.
    Reus WF; Murphy RC; Heggers JP; Robson MC; McCauley RL
    Ann Plast Surg; 1984 Jul; 13(1):29-33. PubMed ID: 6378041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition.
    Edstrom LE; Balkovich M; Slotman GJ
    Ann Plast Surg; 1988 Feb; 20(2):106-11. PubMed ID: 3281544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a thromboxane synthetase inhibitor UK-38,485 on the tolerance of skin flaps of primary ischaemia.
    Mellow CG; Knight KR; Angel MF; O'Brien BM
    Aust N Z J Surg; 1990 Apr; 60(4):293-7. PubMed ID: 2322217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thromboxane synthetase inhibition on tolerance of skin flaps to secondary ischemia caused by venous obstruction.
    Mellow CG; Knight KR; Angel MF; O'Brien BM
    Plast Reconstr Surg; 1990 Aug; 86(2):329-34. PubMed ID: 2367581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic modification of blood flow in the rabbit microvasculature with prostacyclin and related drugs.
    Knight KR; Crabb DJ; Niall M; Angus JA; Martin TJ; O'Brien BM
    Plast Reconstr Surg; 1985 May; 75(5):692-702. PubMed ID: 3157201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The survival of pig to rabbit renal xenografts during inhibition of thromboxane synthesis.
    Jørgensen KA; Kemp E; Barfort P; Starklint H; Larsen S; Petersen PH; Knudsen JB
    Thromb Res; 1983 Dec; 32(6):585-91. PubMed ID: 6364449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM; Moore JN; Hardee GE
    Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the thromboxane synthetase inhibitor dazoxiben and the prostacyclin mimetic iloprost in an animal model of acute ischaemia and reperfusion.
    Thiemermann C; Schrör K
    Biomed Biochim Acta; 1984; 43(8-9):S151-4. PubMed ID: 6083783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do prostacyclin and thromboxane play a role in endotoxic shock?
    Webb PJ; Westwick J; Scully MF; Zahavi J; Kakkar VV
    Br J Surg; 1981 Oct; 68(10):720-4. PubMed ID: 7025959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dazoxiben, an inhibitor of thromboxane synthetase, on forearm vasoconstriction in response to cold stimulation, and on human blood vessel prostacyclin production.
    Cowley AJ; Jones EW; Hanley SP
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):107S-112S. PubMed ID: 6337600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane synthetase inhibition in primary pulmonary hypertension.
    Rich S; Hart K; Kieras K; Brundage BH
    Chest; 1987 Mar; 91(3):356-60. PubMed ID: 3545698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of thrombolytic action of thromboxane synthetase inhibitors.
    Korbut R; Dembińska-Kieć A; Swies J; Zmuda A; Gryglewski RJ
    Thromb Haemost; 1987 Oct; 58(3):827-30. PubMed ID: 3324381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of prostacyclin analogue ZK 36374 and thromboxane synthetase inhibitor UK 38485 on mesenteric ischemia in guinea pigs.
    Aktan AO; Toker A; Bozkurt S; Onuk E; Ercan S
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):163-6. PubMed ID: 1704141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective thromboxane synthase inhibition does not increase in vivo synthesis of prostacyclin in healthy humans.
    Vesterqvist O; Gréen K; Henriksson P; Rasmanis G; Edhag O
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():165-8. PubMed ID: 1825536
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of the rabbit cutaneous microcirculation to prostanoid modifiers as determined by laser Doppler flowmetry.
    Knight KR; Collopy PA; O'Brien BM
    Microvasc Res; 1986 Mar; 31(2):197-202. PubMed ID: 3517597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
    Moriuchi M
    Kokyu To Junkan; 1984 Sep; 32(9):955-61. PubMed ID: 6393261
    [No Abstract]   [Full Text] [Related]  

  • 19. A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2.
    Defreyn G; Deckmyn H; Vermylen J
    Thromb Res; 1982 Jun; 26(6):389-400. PubMed ID: 7051416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thromboxane A2 production does not improve post-ischemic brain hypoperfusion in the dog.
    Prough DS; Kong D; Watkins WD; Stout R; Stump DA; Beamer WC
    Stroke; 1986; 17(6):1272-6. PubMed ID: 3544349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.